Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

International Journal of Gynecological Cancer - United Kingdom
doi 10.1097/igc.0000000000000572
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer With Recurrence Risk

PLoS ONE
Multidisciplinary
2016English

Robotic Surgery in Obese Patients With Early-Stage Endometrial Cancer

Wideochirurgia I Inne Techniki Maloinwazyjne
GynecologySurgeryUrologyObstetricsGastroenterology
2020English

Stratification of Intermediate-Risk Endometrial Cancer Patients Into Groups at High Risk or Low Risk for Recurrence Based on Tumor Gene Expression Profiles

Clinical Cancer Research
Cancer ResearchOncology
2005English

Long Term Benefits of Post-Surgical Adjuvant Radiotherapy Among Sub-Population of Patients With Stage IB Grade 2 Endometrial Cancer

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2011English

High Intermediate Risk Endometrial Cancer. What Is It?

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2019English

Preoperative Factors Related to Stage and Grade Increase in D’Amico Low-Risk and Intermediate-Risk Group Patients

Üroonkoloji Bülteni
2016English

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Mismatch Repair Deficiency Identifies Patients With High-Intermediate-Risk (HIR) Endometrioid Endometrial Cancer at the Highest Risk of Recurrence: A Prognostic Biomarker

Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy